By Dennis Thompson HealthDay ReporterWEDNESDAY, July 9, 2025 (HealthDay News) — A common virus once thought harmless to ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

A groundbreaking new study out of Northwestern Medicine may offer new hope for the more than one million Americans living ...

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

In a small clinical trial in Canada, a medicine commonly found in European cough syrups has shown early signs it might do ...

Parkinson's may be due to environmental causes. One million people have the neurodegenerative disease that robs them of their ...

Researchers believe a usually harmless virus could trigger Parkinson’s disease. The Human Pegivirus (HPgV) belongs to the ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.